Increased adiposity and insulin correlates with the progressive suppression of pulsatile gh secretion during weight gain

Journal of Endocrinology

Volumn 218, Issue 2, 2013, Pages 233-244

  Steyn, F J ^a   Xie, T Y ^a   Huang, L ^a   Ngo, S T ^a   Veldhuis, J D ^b   Waters, M J ^a   Chen, C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MAYO CLINIC   (United States)

Author keywords

adiposity; dietary induced weight gain; insulin; non esterified free fatty acids; pulsatile GH secretion

Indexed keywords

FATTY ACID; GLUCOSE; GROWTH HORMONE; INSULIN; LEPTIN;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; ENERGY BALANCE; EPIDIDYMIS FAT; FAT INTAKE; FAT MASS; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; INSULIN BLOOD LEVEL; LIPID DIET; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WEIGHT GAIN;

ADIPOSITY; ANIMALS; DOWN-REGULATION; GLUCOSE; GROWTH HORMONE; HUMANS; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; OBESITY; WEIGHT GAIN;

EID: 84880696076     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0084     Document Type: Article

References (81)

1. Alvarez CV, Mallo F, Burguera B, Cacicedo L, Dieguez C & Casanueva FF 1991 Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat. Neuroendocrinology 53 185-189. (doi:10.1159/000125716)
2. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM & Tamborlane WV 1984 Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 33 1175-1179. (doi:10.2337/diabetes.33.12.1175)
3. Asplin CM, Faria AC, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD & Evans WS 1989 Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 69 239-245. (doi:10.1210/jcem-69-2-239)
4. Balercia G, Giovannini L, Paggi F, Spaziani M, Tahani N, Boscaro M, Lenzi A & Radicioni A 2011 Growth hormone deficiency in the transition period: body composition and gonad function. Journal of Endocrinological Investigation 34 709-715. (doi:10.10.3275/7804)
5. Barbour L, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S et al. 2005 Increased P85a is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. Journal of Biological Chemistry 280 37489-37494. (doi:10.1074/jbc. M506967200)
6. Bays H 2005 Adiposopathy: role of adipocyte factors in a new paradigm. Expert Review of Cardiovascular Therapy 3 187-189. (doi:10.1586/14779072.3.2.187)
7. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK & Kopchick JJ 2004 Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Hormone & IGF Research 14 309-318. (doi:10.1016/j. ghir.2004.02.005)
8. Boden G & Shulman GI 2002 Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and b-cell dysfunction. European Journal of Clinical Investigation 32(Suppl 3) 14-23. (doi:10.1046/j.1365-2362.32.s3.3.x)
9. Boden G & Zhang M 2006 Recent findings concerning thiazolidinediones in the treatment of diabetes. Expert Opinion on Investigational Drugs 15 243-250. (doi:10.1517/13543784.15.3.243)
10. de Boer H, Blok GJ & Van der Veen EA 1995 Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 16 63-86. (doi:10.1210/er.16.1.63)
11. Boyle PJ, Avogaro A, Smith L, Bier DM, Pappu AS, Illingworth DR & Cryer PE 1992 Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonate levels in normal and diabetic humans. American Journal of Physiology 263 E168-E172.
12. Briard N, Rico-Gomez M, Guillaume V, Sauze N, Vuaroqueaux V, Dadoun F, Le Bouc Y, Oliver C & Dutour A 1998 Hypothalamic mediated action of free fatty acid on growth hormone secretion in sheep. Endocrinology 139 4811-4819. (doi:10.1210/en.139.12.4811)
13. Brons C, Jensen CB, Storgaard H, Hiscock NJ, White A, Appel JS, Jacobsen S, Nilsson E, Larsen CM, Astrup A et al. 2009 Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. Journal of Physiology 587 2387-2397. (doi:10.1113/jphysiol.2009. 169078)
14. Brummer RJ, Lonn L, Kvist H, Grangard U, Bengtsson BA & Sjostrom L 1993 Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy. European Journal of Clinical Investigation 23 199-205. (doi:10.1111/j.1365-2362.1993.tb00762.x)
15. Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabranes JA, Szoke B, Scanlon MF, Schally AV & Fernandez-Cruz A 1987 Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. Journal of Clinical Endocrinology and Metabolism 65 634-642. (doi:10.1210/jcem-65-4-634)
16. Cattaneo L, Colonna VD, Zoli M, Muller EE & Cocchi D 1996 Characterization of the hypothalamo-pituitary-IGF-I axis in rats made obese by overfeeding. Journal of Endocrinology 148 347-353. (doi:10.1677/joe.0.1480347)
17. Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C, Thorner MO & Hartman ML 2001 Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. Journal of Clinical Endocrinology and Metabolism 86 3845-3852. (doi:10.1210/jc.86.8.3845)
18. Collins S, Daniel KW, Petro AE & Surwit RS 1997 Strain-specific response to b3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 138 405-413. (doi:10.1210/en.138.1.405)
19. Cordido F, Penalva A, Peino R, Casanueva FF & Dieguez C 1995 Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects. Metabolism 44 745-748. (doi:10.1016/0026-0495 (95)90187-6)
20. Cordido F, Garcia-Buela J, Sangiao-Alvarellos S, Martinez T & Vidal O 2010 The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors. Mediators of Infiammation 2010 434562. (doi:10.1155/2010/434562)
21. Cornford AS, Barkan AL & Horowitz JF 2011 Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 96 824-830. (doi:10.1210/jc.2010-1895)
22. Cornford AS, Barkan AL, Hinko A & Horowitz JF 2012 Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk. American Journal of Physiology. Endocrinology and Metabolism 303 E1264-E1272. (doi:10.1152/ajpendo. 00320.2012)
23. De Schepper JA, Smitz JP, Zhou XL, Louis O, Velkeniers BE & Vanhaelst L 1998 Cafeteria diet-induced obesity is associated with a low spontaneous growth hormone secretion and normal plasma insulin-like growth factor-I concentrations. Growth Hormone & IGF Research 8 397-401. (doi:10.1016/S1096-6374(98)80310-9)
24. Erman A, Veilleux A, Tchernof A & Goodyer CG 2011a Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women. International Journal of Obesity 35 1511-1519. (doi:10.1038/ijo. 2011.23)
25. Erman A, Wabitsch M & Goodyer CG 2011b Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors. International Journal of Obesity 35 1520-1529. (doi:10.1038/ijo.2011.10)
26. Frayn KN 2002 Adipose tissue as a buffer for daily lipid flux. Diabetologia 45 1201-1210. (doi:10.1007/s00125-002-0873-y)
27. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB & Flier JS 1995 Leptin levels reflect body lipid content in mice-evidence for diet induced resistance to leptin action. Nature Medicine 1 1311-1314. (doi:10.1038/nm1295-1311)
28. Furuhata Y, Kagaya R, Hirabayashi K, Ikeda A, Chang KT, Nishihara M & Takahashi M 2000 Development of obesity in transgenic rats with low circulating growth hormone levels: involvement of leptin resistance. European Journal of Endocrinology 143 535-541. (doi:10.1530/eje.0. 1430535)
29. Ghigo E, Procopio M, Maccario M, Bellone J, Arvat E, Campana S, Boghen MF & Camanni F 1993 Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity? Hormone and Metabolic Research 25 305-308. (doi:10.1055/s-2007-1002105)
30. Gill MS, Toogood AA, O'Neill PA, Adams JE, Thorner MO, Shalet SM & Clayton PE 1997 Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects. Clinical Endocrinology 47 161-167. (doi:10.1046/j.1365-2265. 1997.2291056.x)
31. Girod JP & Brotman DJ 2003 The metabolic syndrome as a vicious cycle: does obesity beget obesity? Medical Hypotheses 60 584-589. (doi:10.1016/S0306-9877(03)00053-7)
32. Gravholt CH, Schmitz O, Simonsen L, Bulow J, Christiansen JS & Moller N 1999 Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. American Journal of Physiology 277 E848-E854.
33. Hansen AP & Johansen K 1970 Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics. Diabetologia 6 27-33. (doi:10.1007/BF00425888)
34. Hayford JT, Danney MM, Hendrix JA & Thompson RG 1980 Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes 29 391-398. (doi:10.2337/diabetes.29.5.391)
35. Huang L, Steyn FJ, Tan HY, Xie TY, Veldhuis JD, Ngo ST & Chen C 2012 The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain. Endocrinology 153 4380-4388. (doi:10.1210/en.2012-1178)
36. Janssen YJ, Frolich M, Deurenberg P & Roelfsema F 1997 Serum leptin levels during recombinant human GH therapy in adults with GH deficiency. European Journal of Endocrinology 137 650-654. (doi:10.1530/eje.0. 1370650)
37. Jorgensen JO, Vahl N, Hansen TB, Thuesen L, Hagen C & Christiansen JS 1996 Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition. Clinical Endocrinology 45 681-688. (doi:10.1046/j.1365-2265.1996.8720883.x)
38. Jorgensen AP, Fougner KJ, Ueland T, Gudmundsen O, Burman P, Schreiner T & Bollerslev J 2011 Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency. Growth Hormone & IGF Research 21 69-75. (doi:10.1016/j.ghir.2011.01.001)
39. Karpe F, Dickmann JR & Frayn KN 2011 Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60 2441-2449. (doi:10.2337/db11-0425)
40. Kuk JL, Church TS, Blair SN & Ross R 2006a Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome? Diabetes Care 29 679-684. (doi:10.2337/diacare.29.03.06.dc05-1500)
41. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN & Ross R 2006b Visceral fat is an independent predictor of all-cause mortality in men. Obesity 14 336-341. (doi:10.1038/oby.2006.43)
42. Lafontan M & Langin D 2009 Lipolysis and lipid mobilization in human adipose tissue. Progress in Lipid Research 48 275-297. (doi:10.1016/j.plipres.2009.05.001)
43. Langin D, Dicker A, Tavernier G, Hoffstedt J, Mairal A, Ryden M, Arner E, Sicard A, Jenkins CM, Viguerie N et al. 2005 Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54 3190-3197. (doi:10.2337/diabetes.54.11.3190)
44. Lauterio TJ, Barkan A, DeAngelo M, DeMott-Friberg R & Ramirez R 1998 Plasma growth hormone secretion is impaired in obesity-prone rats before onset of diet-induced obesity. American Journal of Physiology 275 E6-E11.
45. Li Y, Knapp JR & Kopchick JJ 2003 Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice. Experimental Biology and Medicine 228 207-215.
46. Liuzzi A, Savia G, Tagliaferri M, Lucantoni R, Berselli ME, Petroni ML, De Medici C & Viberti GC 1999 Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. International Journal of Obesity and Related Metabolic Disorders 23 1066-1073. (doi:10.1038/sj.ijo.0801036)
47. Luque RM & Kineman RD 2006 Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 147 2754-2763. (doi:10.1210/en. 2005-1549)
48. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al. 1995 Leptin levels in human and rodent-measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Medicine 1 1155-1161. (doi:10.1038/nm1195-1155)
49. Makimura H, Stanley T, Mun D, You SM & Grinspoon S 2008 The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. Journal of Clinical Endocrinology and metabolism 93 4254-4260. (doi:10.1210/jc.2008-1333)
50. McQuaid SE, Hodson L, Neville MJ, Dennis AL, Cheeseman J, Humphreys SM, Ruge T, Gilbert M, Fielding BA, Frayn KN et al. 2011 Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 60 47-55. (doi:10.2337/db10-0867)
51. Melmed S 1984 Insulin suppresses growth hormone secretion by rat pituitary cells. Journal of Clinical Investigation 73 1425-1433. (doi:10.1172/JCI111347)
52. Melmed S & Slanina SM 1985 Insulin suppresses triiodothyronine-induced growth hormone secretion by GH3 rat pituitary cells. Endocrinology 117 532-537. (doi:10.1210/endo-117-2-532)
53. Melmed S, Neilson L & Slanina S 1985 Insulin suppresses rat growth hormone essenger ribonucleic acid levels in rat pituitary tumor cells. Diabetes 34 409-412. (doi:10.2337/diabetes.34.4.409)
54. Mittendorfer B, Magkos F, Fabbrini E, Mohammed BS & Klein S 2009 Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity 17 1872-1877. (doi:10.1038/oby.2009.224)
55. Moller N, Gjedsted J, Gormsen L, Fuglsang J & Djurhuus C 2003 Effects of growth hormone on lipid metabolism in humans. Growth Hormone & IGF Research 13(Suppl A) S18-S21. (doi:10.1016/S1096-6374(03) 00048-0)
56. Munzberg H, Bjornholm M, Bates SH & Myers MG Jr 2005 Leptin receptor action and mechanisms of leptin resistance. Cellular and Molecular Life Sciences 62 642-652. (doi:10.1007/s00018-004-4432-1)
57. Myers MG, Cowley MA & Munzberg H 2008 Mechanisms of leptin action and leptin resistance. Annual Review of Physiology 70 537-556. (doi:10.1146/annurev.physiol.70.113006.100707)
58. Nam SY & Marcus C 2000 Growth hormone and adipocyte function in obesity. Hormone Research in Paediatrics 53(Suppl 1) 87-97. (doi:10. 1159/000053211)
59. NHMRC 2008 Guidelines to promote the wellbeing of animals used for scientific purposes. Ed CoA. Canberra: National Health and Medical Research Council.
60. Oberbauer AM, Stern JS, Johnson PR, Horwitz BA, German JB, Phinney SD, Beermann DH, Pomp D & Murray JD 1997 Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype. Growth, Development, and Aging 61 169-179.
61. Zata M, Dieguez C & Casanueva FF 2003 The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients. Journal of Clinical Endocrinology and Metabolism 88 312-316. (doi:10.1210/jc. 2002-020122)
62. Park JK, Hong JW, Kim CO, Kim SW, Lim CY, Chung YS, Kim SW & Lee EJ 2011 Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause. Journal of the American Geriatrics Society 59 944-947. (doi:10.1111/j.1532-5415.2011.03382.x)
63. Pomp D, Oberbauer AM & Murray JD 1996 Development of obesity following inactivation of a growth hormone transgene in mice. Transgenic Research 5 13-23. (doi:10.1007/BF01979918)
64. Raabe BM, Artwohl JE, Purcell JE, Lovaglio J & Fortman JD 2011 Effects of weekly blood collection in C57Bl/6 mice. Journal of the American Association for Laboratory Animal Science 5 680-685. (doi:10.1210/jc.80.4.1407)
65. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J & Skakkebae NE 1995 Massive weight loss restores 24-hour growth hormone release profiles and serum insulinlike growth factor-I levels in obese subjects. Journal of Clinical Endocrinology and Metabolism 80 1407-1415. (doi:10.1210/jc.80.4.1407)
66. Renier G, Gaudreau P, Hajjad H, Deslauriers N, Houde-Nadeau M & Brazeau P 1990 Decreased pituitary growth hormone response to growth hormone-releasing factor in cafeteria-fed rats: dietary and obesity effects. Neuroendocrinology 52 284-290. (doi:10.1159/000125599)
67. Rogers P & Webb GP 1980 Estimation of body fat in normal and obese mice. British Journal of Nutrition 43 83-93. (doi:10.1079/BJN19800066)
68. Sauter A, Goldstein M, Engel J & Ueta K 1983 Effect of insulin on central catecholamines. Brain Research 260 330-333. (doi:10.1016/0006-8993(83)90691-1)
69. Savastano S, Di Somma C, Belfiore A, Guida B, Orio F Jr, Rota F, Savanelli MC, Cascella T, Mentone A, Angrisani L et al. 2006 Growth hormone status in morbidly obese subjects and correlation with body composition. Journal of Endocrinological Investigation 29 536-543.
70. Steyn FJ, Huang L, Ngo ST, Leong JW, Tan HY, Xie TY, Parlow AF, Veldhuis JD, Waters MJ & Chen C 2011 Development of a method for the determination of pulsatile growth hormone secretion in mice. Endocrinology 152 3165-3171. (doi:10.1210/en.2011-0253)
71. Steyn FJ, Leong JW, Huang L, Tan HY, Xie TY, Nelson C, Waters MJ, Veldhuis JD, Epelbaum J & Chen C 2012a GH does not modulate the early fasting-induced release of free fatty acids in mice. Endocrinology 153 273-282. (doi:10.1210/en.2011-1681)
72. Steyn FJ, Ngo ST, Lee JD, Leong JW, Buckley AJ, Veldhuis JD, McCombe PA, Chen C & Bellingham MC 2012b Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis. Endocrinology 153 3735-3746. (doi:10.1210/en.2011-2171)
73. Tannenbaum GS, Gurd W & Lapointe M 1998 Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 139 3871-3875. (doi:10.1210/en.139.9.3871)
74. Vahl N, Jorgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H & Christiansen JS 1997 Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. American Journal of Physiology 272 E1108-E1116.
75. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML & Lizarralde G 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism 72 51-59. (doi:10.1210/jcem-72-1-51)
76. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S et al. 1995 Differential impact of age, sex steroid-hormone, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. Journal of Clinical Endocrinology and metabolism 80 3209-3222. (doi:10.1210/jc.80.11.3209)
77. Veldhuis JD, Hudson SB, Erickson D, Bailey JN, Reynolds GA & Bowers CY 2009 Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women. American Journal of Physiology. Endocrinology and Metabolism 297 E367-E374. (doi:10.1152/ajpendo.00230.2009)
78. Veldhuis JD, Roelfsema F, Keenan DM & Pincus S 2011 Gender, age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults. Journal of Clinical Endocrinology and Metabolism 96 115-121. (doi:10.1210/jc.2010-1669)
79. Villafuerte BC, Fine JB, Bai Y, Zhao W, Fleming S & DiGirolamo M 2000 Expressions of leptin and insulin-like growth factor-I are highly correlated and region-specific in adipose tissue of growing rats. Obesity Research 8 646-655. (doi:10.1038/oby.2000.83)
80. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W & Frohman LA 1984 Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. New England Journal of Medicine 311 1403-1407. (doi:10.1056/NEJM198411293112203)
81. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A et al. 2004 Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306 1383-1386. (doi:10.1126/science.1100747)